Literature DB >> 15939390

Transconjunctival Müller muscle recession with levator disinsertion for correction of eyelid retraction associated with thyroid-related orbitopathy.

Guy J Ben Simon1, Ahmad M Mansury, Robert M Schwarcz, Sara Modjtahedi, John D McCann, Robert A Goldberg.   

Abstract

PURPOSE: To evaluate the efficacy of transconjunctival Müller muscle recession and graded levator disinsertion for eyelid retraction in patients with thyroid-related orbitopathy (TRO).
DESIGN: Retrospective consecutive case series.
METHODS: Medical record review of 78 TRO patients (107 eyelids) who underwent surgery for upper eyelid retraction in a 5-year period was performed. Main outcome measures were anatomic and functional success, minimal reflex distance (MRD), lagophthalmos, eyelid asymmetry, and patient discomfort.
RESULTS: One hundred seven eyelid retraction surgeries were performed on 78 TRO patients (63 women, mean age 49 years); mean follow-up time was 16.7 months. Upper eyelid position, lagophthalmos, exposure keratopathy, and patients' discomfort markedly improved after surgery (P < .001). Marginal reflex distance (MRD1) decreased an average of 2.6 mm from 6 mm pre-operatively to 3.4 mm post-operatively (P < .001); lagophthalmos decreased an average of 0.6 mm from 1.3 mm pre-operatively to 0.4 mm post-operatively (P = .006) Failure rate was 8.4%, most improved with a second surgery. Overcorrection was noticed in three cases (2.8%). Eyelid asymmetry improved from a mean of 1.0 mm pre-operatively to 0.4 mm post-operatively (P = .001); more than 80% of patients showed eyelid asymmetry of 1 mm or less.
CONCLUSION: Transconjunctival Müller muscle and levator recession is safe and effective in correction of mild, moderate, or severe eyelid retraction in TRO patients. The failure rate is less than 10% and may be addressed by a second surgery.

Entities:  

Mesh:

Year:  2005        PMID: 15939390     DOI: 10.1016/j.ajo.2005.02.034

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis).

Authors:  Don O Kikkawa
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

2.  Thyroid Eye Disease.

Authors:  Jason Szelog; Hollister Swanson; Matthew C Sniegowski; David B Lyon
Journal:  Mo Med       Date:  2022 Jul-Aug

3.  Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections.

Authors:  Sung Jun Lee; Tyler Hyung Taek Rim; Sun Young Jang; Chan Yun Kim; Dong Yeob Shin; Eun Jig Lee; Sang Yeul Lee; Jin Sook Yoon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-12       Impact factor: 3.117

Review 4.  Management of eyelid retraction related to thyroid eye disease.

Authors:  Tammy H Osaki; Lucas G Monteiro; Midori H Osaki
Journal:  Taiwan J Ophthalmol       Date:  2022-02-14

5.  Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves' Orbitopathy.

Authors:  Miaoli Lin; Yuxiang Mao; Siming Ai; Guangming Liu; Jian Zhang; Jianhua Yan; Huasheng Yang; Aimin Li; Yusha Zou; Dan Liang
Journal:  Int J Endocrinol       Date:  2015-06-29       Impact factor: 3.257

6.  Minimally invasive surgery for thyroid eye disease.

Authors:  Milind Neilkant Naik; Akshay Gopinathan Nair; Adit Gupta; Saurabh Kamal
Journal:  Indian J Ophthalmol       Date:  2015-11       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.